Mentions
Extended reach
Total likes
Video views
AI synopsis
Numerous discussions mention key findings from the study, such as the significant reduction in depression scores with higher doses of psilocybin. Phrases like 'game changer' and 'extraordinary results' illustrate the excitement and high expectations surrounding the potential of psilocybin as a treatment. The tone varies from supportive to cautious, particularly with comments that note associated risks like headaches and suicidal thoughts, indicating a nuanced understanding of psilocybin's complexities.
Many discussions express support for the effectiveness of psilocybin as a treatment, albeit with acknowledgment of its risks.
There is a high level of curiosity about the study and its implications, demonstrated by numerous replies and shared posts.
While many posts show enthusiasm, some merely reference the article without delving into substantive discussions about its content.
The conversations suggest a strong belief that this research could significantly influence treatment practices for major depression.
@ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depression. These have been horse pasted just like HCQ/IVM. https://t.co/PD4rlRjwmm
@MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June. You'll meet many physicians who have witnessed extraordinary results with a drug safer than tylenol. https://t.co/PD4rlRiYwO https://t.co/vMvvBRrJtq https://t.co/wfKOeo3o9E
@MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/PD4rlRiYwO
@CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the research: https://t.co/VvVDH1du8A https://t.co/t9xEN8bhmq
Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
This video examines psilocybin, a psychedelic under investigation for treating treatment-resistant depression. With insights from a recent phase 2 trial, we discuss dosage effects, participant outcomes, and the need for…
Australia has permitted psychiatrists to prescribe MDMA and psilocybin for PTSD and depression after downgrading their classification. While promising, some experts question if this decision is premature, citing…
@KimBrailey94541 @goddeketal Actually, some are very good at treating mental illness. https://t.co/PD4rlRiYwO
@elonmusk @grok Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/8uHEAnFX9C
RT @Kevin_McKernan: @MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June…
RT @Kevin_McKernan: @MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June…
RT @Kevin_McKernan: @MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June…
RT @Kevin_McKernan: @MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June…
RT @Kevin_McKernan: @MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June…
@MdBreathe Not that medical freedom... This medical freedom. You should come to @CannMedEvents in Puerto Rico this June. You'll meet many physicians who have witnessed extraordinary results with a drug safer than tylenol. https://t.co/PD4rlRiYwO https://t.co/vMvvBRrJtq https://t.co/wfKOeo3o9E
@MdBreathe "Psilocybin is being studied for use in treatment-resistant depression. ..psilocybin..reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks but was associated with adverse effects." https://t.co/lmlOzguLjW
RT @Kevin_McKernan: @stephanieseneff They have already banned the most effective one. Therapeutic index of 1000 Single dose results. http…
RT @Kevin_McKernan: @stephanieseneff They have already banned the most effective one. Therapeutic index of 1000 Single dose results. http…
@CartlandDavid https://t.co/5Wd4ct8Uca
RT @Kevin_McKernan: @stephanieseneff They have already banned the most effective one. Therapeutic index of 1000 Single dose results. http…
@stephanieseneff They have already banned the most effective one. Therapeutic index of 1000 Single dose results. https://t.co/PD4rlRiYwO
No son sustancias exentas de riesgo. Por ejemplo, se ha reportado que la psilocibina puede aumentar la ideación suicida (https://t.co/dpgtUvYZkO), o causar trastornos perceptuales crónicos (https://t.co/MrEjNL4AtP), entre otros (+)
RT @psybalazs: * not THE largest, only the 2nd at the moment. My self-blinding #microdose trial (https://t.co/ubAly0A4TE) had n=191 partic…
* not THE largest, only the 2nd at the moment. My self-blinding #microdose trial (https://t.co/ubAly0A4TE) had n=191 participants, but @COMPASSPathway beat me with their #psilocybin vs. TRD trial (https://t.co/riv5K55MdI) that had n=233. However, mine costed ~0.5% to theirs due https://t.co/h33Z45w1Pn
@AaronRosenblum5 @TheBiotechBear @pick1998_2 https://t.co/45o8EZgIUZ 6-8 hrs here
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/LSY2jfoMR2
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
@CannMedEvents Single dose- Not Pharma friendly https://t.co/PD4rlRiYwO
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
RT @Kevin_McKernan: @MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/…
@MikhailaFuller @RobertKennedyJr Psilocybin is safer. Single dose success. Pharma gonna Phight this one! https://t.co/PD4rlRiYwO
RT @gglinskii: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | New England Journal of Medicine https://t.co/…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | New England Journal of Medicine https://t.co/djlNce9RSO
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
@SnAuFlat https://t.co/olqtkYJuSY https://t.co/5anaPOl5W9
@DEAHQ @PoppotGroup Magic mushrooms have been proven to treat and cure Depression, PTSD, and even Addiction: https://t.co/Lx1H7rM9Yy And studies for treating major depression: https://t.co/U9VOSQ7buY
RT @PsilocyberGroup: We will dazzle them with the power of science! TLDR: microdosing is cool and effective, but not as effective as a sing…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression By: New England Journal of Medicine https://t.co/zxTmt6Rvla
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
RT @Kevin_McKernan: @ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depre…
@ShannonJoyRadio Have you see the work on Psilocybin vs SSRIs? Single dose effectiveness for treatment resistant depression. These have been horse pasted just like HCQ/IVM. https://t.co/PD4rlRjwmm
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
@chloe21e8 Aren't psychedelics the chemical manifestation of the universe experiencing itself. Plus they induce neuroplasticity. https://t.co/Qv9fqC32JH https://t.co/hzLA1i2iOv https://t.co/PHS6JZFVx9 https://t.co/SKCrlHu52V https://t.co/pLs47IXSq6
A major study on 233 participants by @COMPASSPathway found that a single dose of psilocybin helped 37% of people with severe depression feel much better, and 29% had their symptoms almost disappear.
@RuhollahSeddigh سلام حتما مستحضر هستید این مواد بصورت کنترل شده و تجویز تحت نظر پزشک در درمان افسردگی هم نقش دارند. مقاله https://t.co/tmGU9OPJ77
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression:https://t.co/NVTuqHRlCb
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
RT @JD_Rosenblat: The much anticipated compass trial is now published @NEJM https://t.co/yc4Qfmride https://t.co/m9gH6AhoZU
RT @StatModeling: Here is the Data Sharing Statement, in its entirety, for Goodwin GM, Aaronson ST, Alvarez O, et al. Single-Dose Psilocybi…
Here is the Data Sharing Statement, in its entirety, for Goodwin GM, Aaronson ST, Alvarez O, et al. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med. DOI: 10.1056/NEJMoa2206443. statmodeling.stat.columbia.edu/2024/10/16/h...
Here is the Data Sharing Statement, in its entirety, for Goodwin GM, Aaronson ST, Alvarez O, et al. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med. DOI: 10.1056/NEJMoa2206443. https://t.co/HhuQ25NpkP
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
@kavehkavoosi @tracyktownsend 25 mg is the dose that @COMPASSPathway is studying in their FDA registration trials. https://t.co/AYQrEUwpUs
@dykesucker @mWhGeK6ebOaxBP4 https://t.co/Tv7h42Ivn6
@tracyktownsend Thanks for this video! I was curious so I dug up links to the studies you mentioned (I also added as a comment on the video): https://t.co/E0K8V6thMc https://t.co/wzxjq4yyBW https://t.co/9tSFdIrig4
Assuming that they still go for the therapy+drug approval, then my bet is a dose-response design similar to the @COMPASSPathway study on psilocybin (https://t.co/wlCFYOoxEW). Something like 1mg vs 60mg vs 120mg with same therapy in all arms. Advantages: - Not perfect, but the https://t.co/fzx8qrF5r2
@iChichosky @PeRR0cK @MentalidadFeroz 2. Aquí te dejo dos papers para que crees tú propia opinión basada en datos científicos. https://t.co/VPMS7fZitF Aquí se demostró que con varias tomas altas de hongos en una muestra "grande" diría yo (79), hay una disminución notable en los problemas y diagnóstico de depresión
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
@RSocPublishing • This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/LCUGscaabt
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
@wolftivy https://t.co/AWRkY8ODbl This is what it's good for. "Single dose application in a professional environment". You blast your brain with dopamine and it tries to "learn how to recreate the moment". If you do it at home as a druggy => Your brain will turn into useless mush.
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
RT @NTFabiano: This mechanism could explain the clinical effectiveness seen for psilocybin in randomized controlled trials. https://t.co/6X…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | New England Journal of Medicine https://t.co/MGk13UhAzX
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | New England Journal of Medicine https://t.co/ywzt3wJkqv
RT @carol_perelman: Ref.: 1) https://t.co/w2fZ9VQEHX 2) https://t.co/47jl6n2mdQ 3) https://t.co/0hlVJU2CzS 4) https://t.co/RNix18KWPg 1…
In one case, the largest trial (NCT03775200) appears to have been included twice in Figure 3, most likely with different outcomes (MADRS reported in the primary report, QIDS-SR-16 in the secondary analysis). https://t.co/CwBYsPXfum
RT @Neurons2Nirvana: @REMAPTherapy @ehaijen @Jfadiman @PaulStamets
@zenbrainest @drrickbarnett @MikaelPalner @trikomes Although:
NEJMでも2022年に。 https://t.co/a96b9dNF7Z
هیچ وقت فکر نمیکردم آخرین تلاشم برای بهتر شدن پیدا کردن magic mushroom باشه... https://t.co/rIMIEQGSyX
RT @DanetRdgz: @BuenoForMiami
@BuenoForMiami
2 of 2 #JournalClub on 11/17/23 presented "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression." Recording is available free to all AAPP members. https://t.co/Uc35d9jWpo https://t.co/1ix20TpOEM
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/SsZm4j8Y7k
RT @carol_perelman: Ref.: 1) https://t.co/w2fZ9VQEHX 2) https://t.co/47jl6n2mdQ 3) https://t.co/0hlVJU2CzS 4) https://t.co/RNix18KWPg 1…
RT @carol_perelman: Ref.: 1) https://t.co/w2fZ9VQEHX 2) https://t.co/47jl6n2mdQ 3) https://t.co/0hlVJU2CzS 4) https://t.co/RNix18KWPg 1…
RT @carol_perelman: Ref.: 1) https://t.co/w2fZ9VQEHX 2) https://t.co/47jl6n2mdQ 3) https://t.co/0hlVJU2CzS 4) https://t.co/RNix18KWPg 1…
RT @carol_perelman: Ref.: 1) https://t.co/w2fZ9VQEHX 2) https://t.co/47jl6n2mdQ 3) https://t.co/0hlVJU2CzS 4) https://t.co/RNix18KWPg 1…
Ref.: 1) https://t.co/w2fZ9VQEHX 2) https://t.co/47jl6n2mdQ 3) https://t.co/0hlVJU2CzS 4) https://t.co/RNix18KWPg 17/fin
Interessante Dose única de psilocibina, o ativo dos
Deadline in 5 days, still doing my evaluation on Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression and i stumble upon this. Nice
@rrhoover @hubermanlab Quick pubmed search answers this, yes: https://t.co/88Qwcuv7Lw https://t.co/2lSj1AHZ25 https://t.co/Xjbw0tW5Wl
From the New England Journal of Medicine: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/S7JWZhJonl
This paper expands on earlier reports of this large phase II COMPASS Pathways study. The authors write: "Background COMP360 is a proprietary, synthetic formulation of psilocybin being developed for treatment-resistant depression (TRD), #Depression https://t.co/7XaADVAV5n https://t.co/uQTMymmLrP
RT @PsyPharmacists: Join us today at 6:00pm ET where we will be discussing the findings from the COMPASS phase 2b trial, “Single-Dose Psilo…
RT @PsyPharmacists: Join us today at 6:00pm ET where we will be discussing the findings from the COMPASS phase 2b trial, “Single-Dose Psilo…
Join us today at 6:00pm ET where we will be discussing the findings from the COMPASS phase 2b trial, “Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression” by Goodwin and colleagues. Link to register can be found in our profile. See you soon! https://t.co/JbXK8pECYJ
RT @PsyPharmacists: Join us for our first journal club event to discuss the COMPASS phase 2b trial, “Single-Dose Psilocybin for a Treatment…
RT @PsyPharmacists: Join us for our first journal club event to discuss the COMPASS phase 2b trial, “Single-Dose Psilocybin for a Treatment…
RT @PsyPharmacists: Join us for our first journal club event to discuss the COMPASS phase 2b trial, “Single-Dose Psilocybin for a Treatment…
Join us for our first journal club event to discuss the COMPASS phase 2b trial, “Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression” by Goodwin and colleagues. Register here: https://t.co/kSrnXKfNS3 https://t.co/ArIf4H77Vn
In @NEJM: Guy M. Goodwin, et. al. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med 2022; 387:1637-1648. November 3, 2022 https://t.co/Aye702YJfc
@PloederlM https://t.co/CwBYsPXfum
Red states join push to legalize #magicmushrooms for therapy https://t.co/RIK1WJXVFy https://t.co/HA7RTKhOln
Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/TBR6JySXuP
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
RT @Dr_Anne_Schlag: Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/xE9Smj2pda
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life https://t.co/uNdGgurOfZ https://t.co/3AcnuO6D9a
Single-dose psilocybin for a treatment-resistant episode of major depr... https://t.co/Rr1u8grXxG
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life... https://t.co/nsB55AoqPA
RT @HealthyFellow: Single-dose #psilocybin for a treatment-resistant episode of major #depression @_atanas_ @_INPST @ScienceCommuni2…
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life https://t.co/KXOpM3Z00a
RT @HealthyFellow: Single-dose #psilocybin for a treatment-resistant episode of major #depression @_atanas_ @_INPST @ScienceCommuni2…
RT @HealthyFellow: Single-dose #psilocybin for a treatment-resistant episode of major #depression @_atanas_ @_INPST @ScienceCommuni2…
RT @HealthyFellow: Single-dose #psilocybin for a treatment-resistant episode of major #depression @_atanas_ @_INPST @ScienceCommuni2…
RT @HealthyFellow: Single-dose #psilocybin for a treatment-resistant episode of major #depression @_atanas_ @_INPST @ScienceCommuni2…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
Single-dose #psilocybin for a treatment-resistant episode of major #depression @_atanas_ @_INPST @ScienceCommuni2 @DHPSP @Grimhood @michaelmantzmd @ChrisPalmerMD @tferriss @MAPS @AzCIM https://t.co/DRFh7Jv3Sq
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
RT @scienceoptics: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the resea…
Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression. #mentalhealth @NEJM Link to the research: https://t.co/VvVDH1du8A https://t.co/t9xEN8bhmq
@REMAPTherapy @ehaijen @Jfadiman @PaulStamets
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM @PsychiatricNews https://t.co/qSadg8dJgm
Parece una excelente herramienta para agregar al arsenal de tratamiento para depresión refractaria. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/U1UuZJbgIH
RT @JoseAntonioPhD: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. https://t.co/Jp7dTIoWdi
RT @JoseAntonioPhD: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. https://t.co/Jp7dTIoWdi
RT @JoseAntonioPhD: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. https://t.co/Jp7dTIoWdi
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. https://t.co/Jp7dTIoWdi
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/ygAuQEShd5
RT @johnrkelly: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/DxJqqSjPQZ @TCINeuroscie…
RT @exosome: To me it is obvious that taking magic mushrooms would take away #depression ...well its good that they showed it in a #clinica…
RT @exosome: To me it is obvious that taking magic mushrooms would take away #depression ...well its good that they showed it in a #clinica…
To me it is obvious that taking magic mushrooms would take away #depression ...well its good that they showed it in a #clinicaltrials https://t.co/Cesp3bwkYR
We begin this episode by discussing two articles of the week, “Single-dose #psilocybin for a treatment-resistant episode of major #depression” and “Short-course vs long-course #antibiotic therapy for #children with @NEJM #mentalhealth
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/J5KtRljxwS
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/sbVhAXUavA
RT @RevistaMFSamfyc: Psilocibina en dosis única para un episodio de depresión mayor resistente al tratamiento https://t.co/C3ZJofYIG6 PMID…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/m5vFXFG4lN
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/gckcKXOsqx
Psilocibina en dosis única para un episodio de depresión mayor resistente al tratamiento https://t.co/C3ZJofYIG6 PMID 36322843
RT @CristinaDragani: Psilocybin given as a single dose of 25 mg is effective in patients with treatment-resistant major #depression, but it…
RT @CristinaDragani: Psilocybin given as a single dose of 25 mg is effective in patients with treatment-resistant major #depression, but it…
Psilocybin given as a single dose of 25 mg is effective in patients with treatment-resistant major #depression, but it has been associated with headaches and nausea. A lower dosage with repeated treatments would have been desirable.
RT @AlexWodak: “In this phase 2 trial involving participants with treatment-resistant depression, psilocybin at a single dose of 25 mg, but…
“In this phase 2 trial involving participants with treatment-resistant depression, psilocybin at a single dose of 25 mg, but not 10 mg, reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks .. ‘ https://t.co/6K6pNi9ZB6
4. 'Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression' (2022) Game changer for new treatment for depression?
PSILOCYBIN UPDATE: It worked at 3 weeks, but not 3 months, in treatment resistant #depression as a single dose along with psychological support. Larger and more rigorous than prior trials. #Psilocybin https://t.co/BOjgFrbv3H https://t.co/6tUy95WCTG
All is not quiet on the #psilocybin #depression front: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | @NEJM https://t.co/T1GsJaXjED
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/GIKQBGLTjS
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/X54egg5OKC
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/muG2u6LqKh
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/1d6evmdykq
RT @briandavidearp: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | NEJM https://t.co/rcPUNEezUo
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/NPCtgWq0hO
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/6i9VfB9Pip
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
https://t.co/NY818LJhpE
RT @MichaelOkun: Beautiful explanation on @NEJMres360 of psilocybin trial just published. 'The primary end point of the trial was the chang…
RT @MichaelOkun: Beautiful explanation on @NEJMres360 of psilocybin trial just published. 'The primary end point of the trial was the chang…
Beautiful explanation on @NEJMres360 of psilocybin trial just published. 'The primary end point of the trial was the change from baseline to week 3 in the total score on the Montgomery–Åsberg.' https://t.co/JrEHdEgUm7 #MedTwitter #Neurotwitter #MedEd #Neurology #dementia #stroke https://t.co/3UkUaZoVBq
Beautiful explanation on @NEJMres360 of psilocybin trial just published. 'The primary end point of the trial was the change from baseline to week 3 in the total score on the Montgomery–Åsberg.' https://www.nejm.org/doi/10.1056/NEJMoa2206443 #MedTwitter #Neurotwitter #MedEd...
Psychedelic 'magic mushroom' drug may ease some depression @nejm https://t.co/RIK1WJXVFy https://t.co/Mb5wzbeJ6O
RT @JasterAlaina: All right it’s the moment you’ve all been waiting for… my thread on the NEJM Compass paper. #JasterNotes https://t.co/J…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/07wW89laqs
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
RT @HealthyFellow: Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @…
Single-Dose #Psilocybin for a Treatment-Resistant Episode of Major #Depression https://t.co/GCqa4ohk57 Attn: @_atanas_ @_INPST @ScienceCommuni2 @DHPSP @ChrisPalmerMD @michaelmantzmd @Grimhood @PaulStamets @NaturalsIndigo @puddleg @MAPS @tferriss @robbwolf @ANUmovie @MSAFungi
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. https://t.co/5bWspihlY2
Single-Dose 25mg Psilocybin for a Treatment-Resistant Episode of Major Depression: Important big study and it informed on dose. Are we close to transformation of clinical practice?https://www.nejm.org/doi/full/10.1056/NEJMoa2206443
RT @JasterAlaina: All right it’s the moment you’ve all been waiting for… my thread on the NEJM Compass paper. #JasterNotes https://t.co/J…
All right it’s the moment you’ve all been waiting for… my thread on the NEJM Compass paper. #JasterNotes https://t.co/J8a5xVbpPs
effects." https://www.nejm.org/doi/full/10.1056/NEJMoa2206443
一般的な抗うつ薬が効かないうつ病患者に、心理的サポートとともにCOMP360シロシビン25mgを投与したら3週間後のうつスコアが大きく低下したという研究がNEJMに掲載されてた。副作用はどの用量群でも確認されてて、25mg群では84％、1mg群（コントロール）で72%。https://t.co/kjHKTw6ChK
Den desidert største psilocybin-studien hittil viser lovende resultater for behandling av behandlingsresistent depresjon med én enkeltdose. https://t.co/qjZOBYYXXl
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression https://t.co/CXPee8LNA6
https://www.sciencemediacentre.org/expert-reaction-to-phase-iib-clinical-trial-of-single-dose-psilocybin-for-a-treatment-resistant-episode-of-major-depression/
expert reaction to Phase IIb Clinical Trial of Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression | Science Media Centre...